More from this Supplier
Supplier
Britannia Pharmaceuticals
Contact
- Address
- Britannia Pharmaceuticals 44-51 Brighton Road Redhill Surrey RH1 6YS UK
- Phone
- 01737 773741
- Fax
- 01737 762672
More stories
Novel asthma treatment comes closer to market
Dry powder synthetic surfactant which shows promise for prophylactic treatment of seasonal allergic asthma and other respiratory conditions to get further development
Automimmune treatment for the UK
Novel treatment for inflammatory related diseases provides a significant alternative to other pharmaceutical therapies
2003 'a landmark year'
Britannia closes 2003 with several new partnership agreements and significant clinical progress, and aims for strategic partnerships to further develop innovative powder treatment for asthma
Bringing drug addiction treatment to the USA
Lofexidine is the only non-opiate, non-addictive treatment approved in the United Kingdom used to manage withdrawal symptoms in patients undergoing opiate detoxification
Advancing development of surgical adhesions
AdSurf is a synthetic surfactant - a unique formulation of the naturally occurring phospholipids dipalmitoylphosphatidycholine and phosphatidyl glycerol


